Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 38.5 - Replacement Pfizer INC

4 Nov 2015 17:48

RNS Number : 6135E
Morgan Stanley Capital Services LLC
04 November 2015
Β 

AMENDMENT (Section 1, 2 a & 2 b)

Β FORM 38.5(a)

Β 

IRISHΒ TAKEOVERΒ PANEL

Β 

DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013

Β 

DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

Β 

Β 

1. KEYΒ INFORMATION

Β Name of exempt market-maker

Morgan Stanley Capital Services LLC

Β Company dealt in

PFIZER INC

Β Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 common stock

Β Date of dealing

29 OCTOBER 2015

Β 

Β 

2. DEALINGSΒ (NoteΒ 2)

Β 

(a) PurchasesΒ andΒ sales

Β Total number of relevant secuities accquired

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

1,152,282

36.0000 USD

34.2500 USD

Β 

Β Total number of relevant secuities disposed

Β Highest price paid (Note 3)

Β Lowest price paid (Note 3)

254,557

36.2000 USD

34.3800 USD

Β 

Β 

Β (b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)

Β 

Β Product name, e.g. CFD

Β Nature of transaction

(Note 4)

Β Number of relevant securities

(Note 5)

Β Price per unit

Β CFD

Β LONG

1

Β 35.2100 USD

Β CFD

Β LONG

4

Β 35.2100 USD

Β CFD

Β LONG

13

Β 35.2100 USD

Β CFD

Β LONG

58

Β 35.2100 USD

Β CFD

Β LONG

77

Β 34.6900 USD

Β CFD

Β LONG

80

Β 35.0700 USD

Β CFD

Β LONG

100

Β 34.7500 USD

Β CFD

Β LONG

200

Β 34.7900 USD

Β CFD

Β LONG

200

Β 35.7150 USD

Β CFD

Β LONG

337

Β 35.2212 USD

Β CFD

Β LONG

350

Β 35.4800 USD

Β CFD

Β LONG

400

Β 35.2213 USD

Β CFD

Β LONG

600

Β 34.8866 USD

Β CFD

Β LONG

700

Β 34.7443 USD

Β CFD

Β LONG

800

Β 35.5925 USD

Β CFD

Β LONG

864

Β 35.2212 USD

Β CFD

Β LONG

1,400

Β 35.7150 USD

Β CFD

Β LONG

2,000

Β 35.2730 USD

Β CFD

Β LONG

2,600

Β 34.8181 USD

Β CFD

Β LONG

12,635

Β 34.6074 USD

Β CFD

Β LONG

15,292

Β 34.9671 USD

Β CFD

Β LONG

42,600

Β 35.2455 USD

Β CFD

Β LONG

99,834

Β 34.7700 USD

Β CFD

Β SHORT

2,400

Β 34.9200 USD

Β CFD

Β SHORT

2,000

Β 34.9500 USD

Β CFD

Β SHORT

10

Β 34.7716 USD

Β CFD

Β SHORT

11

Β 34.7716 USD

Β CFD

Β SHORT

153

Β 34.7706 USD

Β CFD

Β SHORT

200

Β 34.6200 USD

Β CFD

Β SHORT

283

Β 34.7706 USD

Β CFD

Β SHORT

500

Β 34.7980 USD

Β CFD

Β SHORT

750

Β 34.7900 USD

Β CFD

Β SHORT

1,000

Β 34.9390 USD

Β CFD

Β SHORT

1,140

Β 35.1816 USD

Β CFD

Β SHORT

1,700

Β 35.0724 USD

Β CFD

Β SHORT

2,783

Β 34.9322 USD

Β CFD

Β SHORT

4,971

Β 35.1734 USD

Β CFD

Β SHORT

5,400

Β 34.6447 USD

Β CFD

Β SHORT

7,026

Β 34.6516 USD

Β CFD

Β SHORT

8,995

Β 35.1717 USD

Β CFD

Β SHORT

17,000

Β 34.8360 USD

Β CFD

Β SHORT

19,900

Β 34.2951 USD

Β CFD

Β SHORT

20,314

Β 35.0084 USD

Β CFD

Β SHORT

34,800

Β 34.7773 USD

Β CFD

Β SHORT

99,834

Β 34.7700 USD

Β CFD

Β SHORT

379,451

Β 35.2255 USD

Β CFD

Β SHORT

433,915

Β 35.3375 USD

Β 

Β 

(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities

Β 

i) Writing,Β selling,Β purchasingΒ orΒ varying

Β 

Β Product name, eg call option

Β Writing, selling, purchasing, varying etc

Β Number of securities to which the option relates (Note 5)

Β Exercise Price

Β Type, e.g American, European etc

Β Expiry Date

Β Option money paid/received per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β N/A

Β 

(ii) Exercising

Β 

Β Product name, eg call option

Β Number of securities

Β Exercise price per unit (Note 3)

Β N/A

Β N/A

Β N/A

Β 

Β 

3. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Date of disclosure

Β 04 NOVEMBER 2015

Β Contact Name

Craig Horsley

Β Telephone Number

+44(141) 245 7736

Β Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEPKQDQOBDDPDK
Date   Source Headline
1st Mar 20178:51 amRNSPress Release
27th Feb 201710:45 amRNSPress Release
24th Feb 20172:19 pmRNSPress Release
22nd Feb 20177:00 amRNSCancellation of UK Listing
31st Jan 20172:56 pmRNSFourth Quarter and Full-Year 2016 Results
24th Nov 20153:20 pmRNSForm 8.3 - Pfizer Inc
24th Nov 20153:19 pmRNSForm 8.3 - Pfizer, Inc.
24th Nov 201512:14 pmRNSForm 38.5(b) - Pfizer Inc
24th Nov 201511:49 amRNSForm 8.1a - Pfizer Inc
24th Nov 201511:46 amRNSForm 38.5(a) - Pfizer Inc
24th Nov 201510:41 amRNSRule 38.5 - Pfizer INC
24th Nov 20157:00 amRNSForm 38.5(b) - Pfizer Inc
23rd Nov 20156:11 pmRNSForm 38.5(a) - Pfizer Inc
23rd Nov 20155:58 pmRNSForm 8.1a - Pfizer Inc
23rd Nov 20153:40 pmRNSForm 8.3 - PFIZER INC
23rd Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc Amendment
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:28 pmRNSForm 8.3 - ALLERGAN PLC
23rd Nov 20153:21 pmRNSForm 8.3 - Pfizer, Inc.
23rd Nov 20152:56 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:39 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:29 pmRNSForm 8.3 - Allergan Plc
23rd Nov 201512:16 pmRNSForm 8.1 - [Pfizer Inc.]
23rd Nov 201512:04 pmRNSForm 38.5a
23rd Nov 201511:57 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
20th Nov 20153:43 pmRNSForm 8.3 - Pfizer Inc.
20th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
20th Nov 20153:21 pmRNSForm 8.3 - PFIZER INC
20th Nov 20153:17 pmRNSForm 8.3 - ALLERGAN PLC
20th Nov 20153:14 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:11 pmRNSForm 8.3 - [PFIZER INC]
20th Nov 20153:07 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20152:58 pmRNSForm 8.3 - Allergan plc
20th Nov 20152:57 pmRNSRule 38.5 - Replacement Pfizer INC
20th Nov 20152:52 pmRNSForm 8.3 - Allergan Plc
20th Nov 20152:44 pmRNSForm 8.3 - Pfizer, Inc.
20th Nov 201512:14 pmRNSForm 8.1 - [Pfizer Inc]
20th Nov 201511:57 amRNSForm 38.5b
20th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
20th Nov 201511:53 amRNSForm 38.5b
20th Nov 201511:53 amRNSForm 38.5(b) - Pfizer Inc
20th Nov 201511:52 amRNSForm 38.5a
20th Nov 201511:18 amRNSForm 38.5(a) - Pfizer Inc
20th Nov 201510:37 amRNSRule 38.5 - Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.